Hepatitis C Clinical Trials

World-renowned scientists and clinicians at the Center are working collaboratively to understand hepatic disease and to translate scientific research into effective clinical treatment. In addition, at the Center, the diagnostic and therapeutic needs of special sub-populations of patients with chronic hepatitis C warrant particular attention. These include patients with renal failure, HIV co-infection, normal liver enzyme levels, liver transplants, cryoglobulinemia as well as other diseases associated with hepatitis C (e.g. lichen planus, lymphoma).

Patients in trials or undergoing care at the Center are assessed and treated by some of the nations most accomplished physicians in the Weill Cornell Divisions of Gastroenterology and Hepatology, and Departments of Medicine and Surgery.
  • Hepatitis C virus (HCV) affects more than 3 million people nationwide and over a 150 million people worldwide.
  • About 75% of people infected with HCV are unable to eliminate the virus and instead, remain chronically infected.
  • Over a period of 20 or more years, this chronic infection can lead to debilitating and fatal consequences.
Could you have Hepatitis C?